Updated Story CMS has scheduled patient-focused listening sessions from Oct. 30 to Nov 15 to gather drug-specific input as it launches its first round of Medicare price negotiations. Participants will be asked to address the clinical benefits of the first 10 Part D drugs to face negotiations, each drug’s impact on patients and potential clinical alternatives. The speaker registrations will be open until Oct. 2, and are subject to potential changes. The sessions will be open to...